BILLS-119hr3082ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (4)
2025
1998
1ST SESSION H. R. 3082
APRIL 29
EVENT (1)
the ‘‘Evidence-Based Drug
GPE (1)
the United States of America
ORG (12)
Congress
House of Representa-
the Committees on Energy and Commerce
SEC
the Committee on Oversight and Government Reform
Senate
THE HOUSE OF REPRESENTATIVES
U.S.C.
the Office of National Drug
Control Policy Reauthorization Act
the Office of National Drug Control Policy
Reauthorization Act
the Office of National Drug
4
Control Policy Reauthorization Act
PERSON (2)
TITUS
OMAR
Topic Classifications
congressional legislation
97.1%
government oversight
73.3%
public health
27.5%
Extracted Keywords
repeal section
reauthorization act
drug
reauthorization
repeal
act purposes
policy
control
office
repealed verdate
committees energy
thorization act
reform addition
thorization
sec repeal
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20250513010602-04'00'
- Producer
- Acrobat Distiller 24.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20250512235102-04'00'
Sentiment
Polarity
Neutral
-0.050
Subjectivity
33%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.